Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 12/9/2025Ascletis Reports Positive Phase II Results for Oral GLP-1 Agonist ASC3...
  • 12/9/2025Biokin Reports Strong Phase 2 Results for HER2-Targeted ADC T-Bren
  • 12/8/2025Pfizer Files for Approval of Zavegepant Nasal Spray in China
  • 12/8/2025CSPC's Semaglutide Injection Moves Forward — sNDA Accepted, Obesity I...
  • 12/4/2025Lynk Receives FDA IND Approval for Its Brain-Penetrant Allosteric TYK2...
  • 12/1/2025New ADC Shows Broad Antitumor Activity With Strong Bystander Effect
  • 12/1/2025Innovent's Pecondle Wins China Approval as First Homegrown IL-23p19 An...
  • 11/28/2025Gan & Lee Launches GRADUAL-3 Phase 3 Trial of Once-Monthly Bofanglutid...
  • 11/28/2025Zhongmou Reports Strong First-in-Human Results for Optogenetic Gene Th...
  • 11/28/2025BeOne Secures USFDA Priority Review for Sonrotoclax
  • 11/27/2025Novartis's Rhapsido Approved for Chronic Spontaneous Urticaria in Chin...
  • 11/27/2025Ascentage Pharma Publishes Phase Ib Data for Olverembatinib in GIST
  • 11/27/2025NMPA Approves AstraZeneca's Imfinzi for NSCLC in China
  • 11/27/2025Biontech to Present Phase 2 Data for Bispecific Antibody Pumitamig in ...
  • 11/27/2025CSPC's JMT206 Wins Green Light for First-in-Human Trials in China
  • 11/27/2025Sugemalimab Wins European Approval for Stage III NSCLC
  • 11/25/2025Kelun Reports Positive Phase 2 Results for Sac-TMT Combined with KEYTR...
  • 11/25/2025Luye Pharma Receives FDA IND Clearance for LY03017
  • 11/25/2025Huaota Reports Pivotal Phase 3 Success for HB0017
  • 11/25/2025Pfizer's Hympavzi (Marstacimab) Gains NMPA Approval in China
  • 11/21/2025CSPC Advances Nectin-4 ADC SYS6002 Into First Phase 3 Trial
  • 11/21/2025Lynk Reports Positive Phase II Results for Topical JAK Inhibitor
  • 11/21/2025Innovent Moves Toward China Filing After High-Dose Obesity Drug Delive...
  • 11/20/2025Innovent's Mazdutide Achieves Strong Phase 3 Results in Chinese Obesit...
  • 11/19/2025China Accelerates Animal Testing in Ambitious Biotech Push
  • 11/18/2025Roche's Subcutaneous PD-L1 Therapy Wins China Approval
  • 11/18/2025Sinovac Expands Flu Vaccine Use to Infants from 6 Months
  • 11/18/2025Qilu to Share First-in-Human Data of Trispecific Antibody QLS4131 at A...
  • 11/18/2025Akeso's First CNS Candidate Cleared for Alzheimer's Clinical Trials in...
  • 11/18/2025Henlius and Organon Score First Interchangeable Biosimilar to Perjeta
  • Page:1/20 Total number of articles:595: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group